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New technology
!
The adenoma detection rate is a critical statistic
for colonoscopy. Current technology may be lim-
ited in its ability to see behind folds, which may
result in missed polyps. A new colonoscope was
introduced this year called the PeerScope (Peer-
Medical Ltd, Caesarea, Israel) [1]. It is character-
ized by having 2 viewing modes: a 160-degree
forward-viewing mode and a 330-degree or
greater full-spectrum view. The new colonoscope
maintains the standard features a colonoscope
such as tip deflection, working channel, suction,
and irrigation. The general functionality of the co-
lonoscope was tested in 50 patients, and the re-
sults revealed a 100% cecal intubation rate, mean
time to the cecum of 3.1 minutes, and a total pro-
cedure time of 15 minutes. Intubation of the ileo-
cecal valve was achieved in 46% of the patients.
Forty-four percent of the patients underwent for-
ceps biopsy or snare polypectomy. The abstract
suggests that this new colonoscope has function-
ality comparable to that of standard colono-
scopes, but the key issue will be whether this
new instrument will improve adenoma detection
by reducing the missed polyp rate.
Many gastroenterologists believe that the future
of screening and surveillance endoscopy lies
with capsule technology. It is unlikely, however,
that adequate visualization of the GI tract can be
achieved without controlling the direction and
transit speed of the capsule. A new capsule tech-
nology was introduced this year consisting of a
radio-controlled, motor-driven capsule [2]. The
prototype is composed of 2 parts: an imaging
unit (PillCam SB2, Given Imaging Co, Yokneam, Is-
rael) and a motor-driven unit. The motor drive
consists of micro DC motor, and a control signal
receiver. The device was tested for suitability and
safety in the GI tract of the dog. Experiments
showed that maneuverability within the GI tract
was adequate but maintaining its position against
peristalsis and postural changes was difficult. The
force of the motor was inadequate to overcome
peristalsis and contraction of the sphincter, and
although battery life was limited, evaluation of
the stomach and colon was possible. The radio-
control system was easy to use, portable, and in-
expensive. This technology will need to be re-
fined, but if an inexpensive, remote-control cap-
sule system can be developed, this will rapidly
and significantly advance our ability to screen
and survey the GI tract noninvasively.
New platforms
!
Since the beginning of natural orifice translumin-
al endoscopic surgery (NOTES) and with publica-
tion of the first white paper, many therapeutic
endoscopists have believed that there is a signifi-
cant clinical need for a new flexible endoscopic
platform. A critical function of the new platform
would be the ability to triangulate. This year, we
saw the introduction of the Endomina system
(MEDI-LINE SA, Liege, Belgium), which is a univer-
sal triangulation platform adaptable to a flexible
endoscope [3]. The device consists of a 20-mm
overtube with 2 integrated articulating arms that
can accommodate 9F instruments. Any flexible
endoscope can be passed through the overtube.
The device is robotized, and the articulating arms
have 3 degrees of freedom. The robotized arms
can accommodate various accessories and are
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Overall, Digestive Disease Week (DDW) 2013 was
an excellent year for endoscopic innovation. For
this section, the abstracts have been divided into
new technologies and new techniques. The ab-
stracts selected for review are ones that represent
material that has a reasonable chance of affecting
the practice of GI endoscopy.
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moved by a joystick. The system allows the endoscopist to lift and
cut and oppose and suture tissue and therefore has the potential
to make endoscopic submucosal dissection (ESD) easier and may
even be able to perform full-thickness resection. The system has
been used to perform complex tissue resection and anterior pos-
terior tissue apposition in various models, and use in humans has
begun. A flexible endoscopic system that allows triangulation
and complex movements within the GI tract would be a very im-
portant advance for therapeutic endoscopy.
As new platforms are developed for NOTES, it will be necessary to
develop systems for tactile and kinesthetic feedback. Such a sys-
tem was reported on this year in which a device consisting, in
part, of an external magnetic field source was used to assess in-
dentation depth [4]. Three different silicone-based tissue phan-
toms were created, each with a unique stiffness. The phantoms
were first palpated with the operator’s dominant index finger.
The phantoms were then palpated by using the novel palpation
system in which indentation depth and the exerted force were
measured, providing the local elastic module as a quantitative
measure of the sample stiffness. The wireless tissue palpation
system achieved a precision of 96.9% in reconstructing the
achieved indentation depth based on magnetic field measure-
ments. This innovative approach to tissue palpation has the po-
tential to open up a new paradigm in the field of NOTES where
no mechanical link between the external platform and the target
region exists. Investigators will continue to work on miniaturiza-
tion and then will begin ex vivo and in vivo trials.
New techniques
!
Luminal obstruction with inflammation and abscess formation is
thought to be the etiology of acute appendicitis. Appendectomy
is the standard treatment. This year, a multicenter, retrospective
report from China described endoscopic retrograde appendicitis
therapy (ERAT) [5]. Thirty-four patients with a clinical suspicion
of acute appendicitis were included in this study. Colonoscopy
was performed, and positive findings included bulging, edema,
and pus drainage. Endoscopic appendiceal intubation was suc-
cessful in 33 of 34 patients (97%). Four patients had negative
findings, and appendiceal decompression was performed in all
29 of the remaining patients consisting of cleansing of the ap-
pendiceal lumen in 19 of 29 (66%) and stent drainage in 10 of 29
(34%). Abdominal pain was improved immediately in all treated
patients, and rebound tenderness and guarding disappeared
within 12 hours in 27 of 29 patients. Recurrent appendicitis de-
veloped in 2 patients (6.9%) 1 to 36 months later, and surgical in-
tervention was required. This could become an alternative treat-
ment when surgery is not possible.
Suturing
With the inception of NOTES, it was thought that the develop-
ment of an endoscopic suturing device would be required. Such
a device is available that is capable of performing interrupted or
continuous sutures by using a double-channel endoscope (Over-
stitch, Apollo Endosurgery, Austin, Tex). There were several ab-
stracts this year describing the use of this endoscopic suturing a
device. Kantevoy et al [6] reported on closure of large mucosal
defects after ESD and suggested that such closure could eliminate
the need for hospital admission. Nine patients were included in
this report (3 stomach, 6 colon), with an average lesion size of
38 ± 10mm. All 9 patients had successful closure of the ESD de-
fect, with 7 requiring only 1 stitch (continuous suture) and 2 pa-
tients requiring 2 separate stitches. There were no immediate or
delayed adverse events.
There were 2 reports on the use of Overstitch to fix esophageal
stents. In 1 report, 14 patients underwent anchoring of esopha-
geal stents [7]. The technical success rate for stent placement
and fixation was 100% by using 1 to 5 sutures. There were no ad-
verse events specifically related to suturing. Stent migration oc-
curred in 3 patients (21%). However, stent migrationwas preven-
ted in 5 of 7 patients (71%) in whom previous stent placement
had resulted in migration.
In the other report [8], 30 patients underwent placement of a
fully covered esophageal stent. Twelve patients received sutures
to fix the stent. One or 2 sutures were placed, and suturing was
technically successful in 100% of patients. Stent migration was
noted in 1 of 2 patients (8%) in whom sutures were placed and
in 10 of 17 patients (59%) with no sutures (P= .04). These reports
suggest that when placing a fully covered esophageal stent, mi-
gration can often be prevented by anchoring the stent with su-
tures.
Submucosal tunneling
The development of peroral endoscopic myotomy (POEM) has
opened up a new discipline of submucosal endoscopic surgery.
This year, there were multiple abstracts describing the use of
the submucosal tunneling technique to resect submucosal tu-
mors, divide the pyloric sphincter, or sever the muscular propria
to treat achalasia. The first article describes the use of the tech-
nique to resect submucosal tumors at the esophagogastric (EG)
junction originating from the muscularis propria [9]. This study
from China described 57 patients who underwent resection of
the EG junction for leiomyomas or GI stromal tumors by using
the tunneling technique. Their experience indicates that main-
taining proper direction of the tunnel and mucosal integrity is
imperative. The average lesion size was 21.5mm, and en bloc re-
sectionwas successful in 100% with negative lateral and deep tu-
mor-free margins in all cases. There were no delayed hemorrha-
ges, and pneumothorax developed in 2 patients requiring chest
tubes, but surgery was avoided. There was no local recurrence
or distant metastases during 12 months follow-up.This tech-
nique is elegant and offers a less invasive technique compared
with surgery. The long tunnel provides secure sealing of the gut
even if the muscularis propria is resected.
Another report from China described tunneling to resect submu-
cosal tumors in 151 consecutive patients [10]. The mean tumor
size was 21mm, the histology included GI stromal tumors and
leiomyomas, and most were located in the esophagus or EG junc-
tion (72.4% and 19.7%, respectively). The en bloc resection rate
was 86%with complete R0 resection in 83% and an adverse event
rate of 35.5%. Virtually all of the adverse events were related to
air insufflation and consisted of pneumothorax in 17%, subcuta-
neous/mediastinal air in 28%, and pneumoperitoneum in 14.5%.
The mean procedure time was 1 hour. This larger study certainly
establishes the feasibility of removing submucosal tumors arising
from the muscularis propria by using the submucosal tunneling
technique. It has become standard of practice to use CO2 for all
cases, which significantly reduces the adverse events, as de-
scribed in this study.
This same tunneling technique has now been described to per-
form peroral endoscopic pyloromyotomy [11]. A submucosal
bleb followed by a mucosal incision was made 10cm proximal to
the pylorus in a swinemodel. Tunneling was performed by stand-
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ard submucosal dissection technique until the pylorus was tra-
versed. A TT knife (Olympus America Inc, Center Valley, Pa) along
with spray coagulation (50W, E2; ERBE, Marietta, Ga) was used
to hook and divide the inner transverse and obliquemuscle fibers
leaving the outer longitudinal fibers intact. The procedure was
performed on 5 pigs followed by euthanasia and autopsy. In the
first 2 pigs, an incomplete pyloromyotomywas found, but the py-
loromyotomy was complete in the remaining 3 pigs. The investi-
gators measured the “ease of passage” of the endoscope before-
and-after myotomy, and this measure improved from a mean
score of 3.8 to 1.6.The results of this report suggest that this tech-
nique is promising, but additional animal survival datawill be re-
quired to validate the technique before it is ready for human test-
ing.
EUS-guided therapies
The use of EUS to guide novel therapies is gaining momentum.
This year at DDW, there were several abstracts describing novel
treatments delivered by EUS guidance. The first abstract de-
scribed the treatment of 8 patients, 6 with cystic neoplasms and
2 with cystic degeneration of neuroendocrine tumors by using
radiofrequency (RF) energy [12]. The investigators used a novel
RF device (1.2-mm Habib EUS-RF ablation catheter, Emcision
Ltd, London, UK) passed through a 19–or 22-gauge needle. The
RF energy was applied at increasing dosimetry beginning at 5W
and ending at 25W delivered over 90 seconds. The median num-
ber of applications per session was 4.5 (range 2–7). Among the 6
patients with cystic neoplasms, imaging at 3 to 6months demon-
strated complete resolution of the cyst in 2 patients, whereas in 3
patients, there was a 48% reduction in size. In the 2 neuroendo-
crine tumor patients, a change in vascularity and central necrosis
was demonstrated, but the tumors did not disappear. The chal-
lenge in applying this technology for cystic neoplasms will be to
get even and sufficient distribution of energy into a complex 3-
dimensional structure to achieve a complete ablation.
There have been multiple trials investigating EUS-guided injec-
tion therapy (fine-needle injection [FNI]) primarily in pancreatic
cancer. Regrettably, all to date have failed to show benefit in sur-
vival. This year there was a report of new EUS-guided intratu-
moral therapy by using a recombinant pox viral vaccine (Panvac)
that encodes tumor antigens (carcinoembryonic antigen and
Muc1 and 3) and 3 immune costimulatory antigens [13]. The
study enrolled 13 patients with locally advanced inoperable pan-
creatic adenocarcinoma who received 2 EUS-guided FNI treat-
ments given 2 weeks apart at 2 different dose levels (dose 1 and
2). The results showed in the lower dose cohort that 2 of 7 pa-
tients had to be removed from the study because of rapid disease
progression. Mild pancreatitis developed in 1 patient (but treat-
ment continued), and 2 patients are alive at 15 and 30 months
into follow-up. In the higher dose cohort, 3 patients are alive at
2, 8, and 10 months, respectively. These are very preliminary,
phase 1 results, and we have seen multiple other trials with sim-
ilar encouraging results early on. We must wait for results from a
phase 2 study that has been initiated.
There been several previous reports on EUS-guided intravascular
therapy. This year, there was a study of 25 patients with liver me-
tastases secondary to colorectal cancer treated with 5-flurouracil
or 5-fluorodeoxymidina injected into the hepatic artery either
under EUS guidance (n=12) or by the conventional approach
with an implanted infusion pump (n=13) [14]. The investigators
looked at technical outcomes, treatment response, and safety
profile. Responses were similar for tumor response (85% vs 90%)
and median survival (9–19 months vs 12–17 months) for FNI
and the conventional approach, respectively. However, the num-
ber of adverse events was significantly higher with the conven-
tional approach (33% vs 76%, P= .03), which included abdominal
pain, port infection emboli, and thrombosis. The adverse events
for the conventional approach seem high in this report and may
be related to an indwelling device versus repeated applications
with EUS.Costs were not included in this study, but would seem
likely to be higher for EUS because of the need for repeated appli-
cations. Nevertheless, EUS-guided vascular interventions deserve
further study [15–24].
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